Literature DB >> 18406474

Bickerstaff's brainstem encephalitis after an outbreak of Campylobacter jejuni enteritis.

Masahiro Mori1, Michiaki Koga, Nobuhiro Yuki, Takamichi Hattori, Satoshi Kuwabara.   

Abstract

Twenty-eight patients suffered Campylobacter jejuni enteritis after eating raw chicken. Among them, only one patient developed Bickerstaff's brainstem encephalitis, who carried anti-GQ1b IgG antibodies. In contrast, none of the others did the autoantibodies. C. jejuni was cultured from all stool samples from five patients with enteritis alone. All the isolates had the same genotype, cst-II (Asn51), which are characteristic of strains isolated from Bickerstaff's brainstem encephalitis. These findings suggest that host susceptibility may play a role in inducing the production of anti-ganglioside antibodies and the development of Bickerstaff's brainstem encephalitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406474     DOI: 10.1016/j.jneuroim.2008.02.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Neuro-ophthalmology and the Anti-GQ1b antibody syndromes.

Authors:  Robert F Saul
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

2.  Analysis of Campylobacter jejuni isolates of various sources for loci associated with Guillain-Barré Syndrome.

Authors:  P Amon; D Klein; B Springer; S Jelovcan; D Sofka; F Hilbert
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-03-17

3.  First report of Bickerstaff's brainstem encephalitis caused by Salmonella Dublin: a case report.

Authors:  Jiangbo Xie; Tingting Zhang; Tao Liu
Journal:  BMC Neurol       Date:  2021-05-15       Impact factor: 2.474

4.  Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice.

Authors:  Markus M Heimesaat; Dennis Weschka; Soraya Mousavi; Stefan Bereswill
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.